BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11485141)

  • 1. Linear immunoglobulin A bullous dermatosis induced by gemcitabine.
    del Pozo J; Martínez W; Yebra-Pimentel MT; Almagro M; Peña-Penabad C; Fonseca E
    Ann Pharmacother; 2001; 35(7-8):891-3. PubMed ID: 11485141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced linear immunoglobulin A bullous dermatosis mimicking Stevens-Johnson syndrome: a case report.
    Cummings JE; Snyder RR; Kelly EB; Raimer SS
    Cutis; 2007 Mar; 79(3):203-7. PubMed ID: 17674585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naproxen-associated linear IgA bullous dermatosis: case report and review.
    Bouldin MB; Clowers-Webb HE; Davis JL; McEvoy MT; Davis MD
    Mayo Clin Proc; 2000 Sep; 75(9):967-70. PubMed ID: 10994833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bullous dermatosis associated with gemcitabine therapy for non-small-cell lung carcinoma.
    Imen A; Amal K; Ines Z; Sameh el F; Fethi el M; Habib G
    Respir Med; 2006 Aug; 100(8):1463-5. PubMed ID: 16434173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced linear IgA bullous dermatosis.
    Onodera H; Mihm MC; Yoshida A; Akasaka T
    J Dermatol; 2005 Sep; 32(9):759-64. PubMed ID: 16361722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literature.
    Plunkett RW; Chiarello SE; Beutner EH
    J Am Acad Dermatol; 2001 Nov; 45(5):691-6. PubMed ID: 11606917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A successful challenge in a patient with vancomycin-induced linear IgA dermatosis.
    Joshi S; Scott G; Looney RJ
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):101-3. PubMed ID: 15281479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency.
    Klein PA; Callen JP
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 2):316-23. PubMed ID: 10640923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amoxicillin-clavulanic acid-induced linear immunoglobulin A bullous dermatosis: case report and review of the literature.
    Panasiti V; Rossi M; Devirgiliis V; Curzio M; Bottoni U; Calvieri S
    Int J Dermatol; 2009 Sep; 48(9):1006-10. PubMed ID: 19702992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
    Waldman MA; Black DR; Callen JP
    Clin Exp Dermatol; 2004 Nov; 29(6):633-6. PubMed ID: 15550142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis.
    Kovacic D; Fox M; Reichenberg J
    J Drugs Dermatol; 2008 Aug; 7(8):794-5. PubMed ID: 18720700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of linear immunoglobulin A bullous dermatosis in a patient exposed to sun and an analgesic.
    Pellicano R; Caldarola G; Cozzani E; Parodi A
    Clin Ther; 2009 Sep; 31(9):1987-90. PubMed ID: 19843488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear IgA bullous dermatosis following influenza vaccination.
    Alberta-Wszolek L; Mousette AM; Mahalingam M; Levin NA
    Dermatol Online J; 2009 Nov; 15(11):3. PubMed ID: 19951639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature.
    Kuechle MK; Stegemeir E; Maynard B; Gibson LE; Leiferman KM; Peters MS
    J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):187-92. PubMed ID: 7904616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin-induced linear IgA bullous dermatosis: morphology is a key to diagnosis.
    Solky BA; Pincus L; Horan RF
    Cutis; 2004 Jan; 73(1):65-7. PubMed ID: 14964634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 associated linear IgA bullous dermatosis.
    Tranvan A; Pezen DS; Medenica M; Michelson GC; Vogelzang N; Soltani KM
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 2):865-7. PubMed ID: 8912608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis.
    Billet SE; Kortuem KR; Gibson LE; El-Azhary R
    Arch Dermatol; 2008 Jun; 144(6):774-8. PubMed ID: 18559768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced linear IgA bullous dermatosis probably induced by furosemide.
    Cerottini JP; Ricci C; Guggisberg D; Panizzon RG
    J Am Acad Dermatol; 1999 Jul; 41(1):103-5. PubMed ID: 10411419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme.
    Armstrong AW; Fazeli A; Yeh SW; Mackool BT; Liu V
    J Cutan Pathol; 2004 May; 31(5):393-7. PubMed ID: 15059226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous dermatosis associated with vancomycin extravasation.
    Bohm NM; Wong JG
    Am J Med Sci; 2012 Feb; 343(2):177-179. PubMed ID: 22104428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.